From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA rejects Merck's bone cancer treatment

from The Wall Street Journal

Merck said the Food and Drug Administration rejected its new drug application for an investigational maintenance treatment for patients with metastatic soft tissue or bone sarcoma. The company said it received a complete response letter from the FDA, which said further clinical trials of the treatment — ridaforolimus — would be needed to assess its effectiveness and safety before any potential approval. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063